208 related articles for article (PubMed ID: 7429678)
1. Influence of route of administration on haloperidol plasma levels in psychotic patients.
Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
[TBL] [Abstract][Full Text] [Related]
2. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
[TBL] [Abstract][Full Text] [Related]
3. [Haloperidol. Plasma monitoring and hormonal effects of treatment].
Goyot C; Debray Q; Dugas M; Guay C; Giraud J; Grenier J
Pathol Biol (Paris); 1985 Dec; 33(10):999-1004. PubMed ID: 2937009
[TBL] [Abstract][Full Text] [Related]
4. Elimination half-life and bioavailability of haloperidol in schizophrenic patients.
Magliozzi JR; Hollister LE
J Clin Psychiatry; 1985 Jan; 46(1):20-1. PubMed ID: 3965439
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacokinetic of haloperidol decanoate in psychotic patients (author's transl)].
Parent M; Toussaint C; Driesens F; Gelders Y
Acta Psychiatr Belg; 1981; 81(4):399-406. PubMed ID: 7331843
[No Abstract] [Full Text] [Related]
6. Blood levels of haloperidol in schizophrenic patients.
Shvartsburd A; Dekirmenjian H; Smith RC
J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
[TBL] [Abstract][Full Text] [Related]
7. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
[TBL] [Abstract][Full Text] [Related]
8. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
Shostak M; Perel JM; Stiller RL; Wyman W; Curran S
J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700
[TBL] [Abstract][Full Text] [Related]
9. Serum haloperidol concentrations and clinical response in acute psychosis.
Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens.
Bugyei K; Black WD; McEwen S
Can J Vet Res; 1999 Jul; 63(3):193-200. PubMed ID: 10480461
[TBL] [Abstract][Full Text] [Related]
11. Correlates of early neuroleptic response using a uniform haloperidol dose.
Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
[TBL] [Abstract][Full Text] [Related]
12. Oral versus intravenous vinorelbine: clinical safety profile.
Gebbia V; Puozzo C
Expert Opin Drug Saf; 2005 Sep; 4(5):915-28. PubMed ID: 16111453
[TBL] [Abstract][Full Text] [Related]
13. [Use of very high doses of haloperidol in the treatment of acute psychotic episodes. Clinical and pharmacokinetic analysis apropos of 15 cases].
Petit P; Blayac JP; Castelnau D; Billet J; Puech R; Pouget R
Encephale; 1987; 13(3):127-30. PubMed ID: 3595515
[TBL] [Abstract][Full Text] [Related]
14. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
Reschke RW
Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of haloperidol in psychotic patients.
Cheng YF; Paalzow LK; Bondesson U; Ekblom B; Eriksson K; Eriksson SO; Lindberg A; Lindström L
Psychopharmacology (Berl); 1987; 91(4):410-4. PubMed ID: 3108922
[TBL] [Abstract][Full Text] [Related]
16. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
17. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Chouinard G; Safadi G; Beauclair L
J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
[TBL] [Abstract][Full Text] [Related]
18. Plasma level and effect of low-dose haloperidol in acute psychosis.
Bleeker JA; Dingemans PM; Frohn-de Winter ML; van de Slooten EP
Psychopharmacol Bull; 1984; 20(2):317-9. PubMed ID: 6728996
[No Abstract] [Full Text] [Related]
19. Acutely psychotic patients receiving high-dose haloperidol therapy.
Remington G; Pollock B; Voineskos G; Reed K; Coulter K
J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability of intramuscular versus oral haloperidol in schizophrenic patients.
Schaffer CB; Shahid A; Javaid JI; Dysken MW; Davis JM
J Clin Psychopharmacol; 1982 Aug; 2(4):274-7. PubMed ID: 7119135
[No Abstract] [Full Text] [Related]
[Next] [New Search]
